International evaluation of the SEIZUre Risk in Encephalitis (SEIZURE) score for predicting acute seizure risk
Open Access
Abstract
Objective: Encephalitis is brain parenchyma inflammation, frequently resulting in seizures which worsens outcomes. Early anti-seizure medication could improve outcomes but requires identifying patients at greatest risk of acute seizures. The SEIZURE (SEIZUre Risk in Encephalitis) score was developed in UK cohorts to stratify patients by acute seizure risk. A ‘basic score’ used Glasgow Coma Scale (GCS), fever and age; the ‘advanced score’ added aetiology. This study aimed to evaluate the score internationally to determine its global applicability. Design: Patients were retrospectively analysed regionally, and by country, in this international evaluation study. Univariate analysis was conducted between patients who did and did not have inpatient seizures, followed by multivariable logistic regression, hierarchical clustering and analysis of the area under the receiver operating curves (AUROC) with 95% CIs. Participants and setting: 2032 patients across 13 countries were identified, among whom 1324 were included in SEIZURE score calculations and 970 were included in regression modelling. The involved countries comprised 19 organisations spanning all WHO regions. Outcome measures: The primary outcome was measuring inpatient seizure rates. Results: Autoantibody-associated encephalitis, low GCS and presenting with a seizure were frequently associated with inpatient seizures; fever showed no association. Globally, the score had limited discriminatory ability (basic AUROC 0.58 (95% CI 0.55 to 0.62), advanced AUROC 0.63 (95% CI 0.60 to 0.66)). The scoring system performed acceptably in western Europe, excluding Spain, with the best performance in Portugal (basic AUROC 0.82 (95% CI 0.69 to 0.94), advanced AUROC 0.83 (95% CI 0.72 to 0.95)). Conclusions: The SEIZURE score performed best in several countries in Western Europe but performed poorly elsewhere, partly due to differing and unknown aetiologies. In most regions, the score did not reach a threshold to be clinically useful. The Western European results could aid in designing clinical trials assessing primary anti-seizure prophylaxis in encephalitis following further prospective trials. Beyond Western Europe, there is a need for tailored, localised scoring systems and future large-scale prospective studies with optimised aetiological testing to accurately identify high-risk patients.Keywords
Funding Information
- National Institute for Health Research Health Protection Research Unit (200907)
- National Institute for Health Research Health Protection Research Unit (200927)
- National Institute of Neurological Disorders and Stroke (R01NS126156)
- NIHR I4I FAST (NIHR208981)
- Medical Research Council (MR/T028750/1)
- Medical Research Council (MR/V007181/1)
- Medical Research Council (MR/V03605X/1)
- Wellcome Trust (315711/Z/24/Z)
- Wellcome Trust (ISSF201902/3)
- NIHR Health Protection Research Unit in Emerging and Zoonotic Infections (IS-HPU-1112-10117),)
This publication has 27 references indexed in Scilit:
- Characteristics, management and outcome of Herpes Simplex and Varicella-Zoster virus encephalitis: a multicentre prospective cohort studyClinical Microbiology and Infection, 2024
- Global magnitude of encephalitis burden and its evolving pattern over the past 30 yearsJournal of Infection, 2022
- Autoimmune encephalitis as an increasingly recognised cause of non-convulsive status epilepticus: A retrospective, multicentre evaluation of patient characteristics and electroencephalography (EEG) resultsSeizure: European Journal of Epilepsy, 2020
- Autoimmune encephalitis epidemiology and a comparison to infectious encephalitisAnnals of Neurology, 2018
- Time‐dependent risk of seizures in critically ill patients on continuous electroencephalogramAnnals of Neurology, 2017
- Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and ManagementNeurotherapeutics, 2016
- Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort studyThe Lancet Neurology, 2013
- Early peak temperature and mortality in critically ill patients with or without infectionIntensive Care Medicine, 2012
- Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective studyThe Lancet Infectious Diseases, 2010
- Seizures in encephalitis: Predictors and outcomeSeizure: European Journal of Epilepsy, 2009